| ID | 659 |
|---|
| No | 659 |
|---|
| Brand Name | ALLRECOV |
|---|
| Ingredients | NALTREXONE HYDROCHLORIDE 150 MG |
|---|
| Dosage Form | IMPLANT |
|---|
| Primary Packaging | VIAL |
|---|
| Storage | STORE BELOW 30 C |
|---|
| Shelf Life | 24 MONTHS |
|---|
| Pack Size | BOX OF 10 TABLETS/VIAL |
|---|
| Dispensing Category | PRESCRIPTION |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | OTHER NERVOUS SYSTEM DRUGS |
|---|
| Indications | for the prevention of relapse following opioid detoxification in patients with opioid dependence. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
No |
|---|
| Description | The product is a light yellow to yellow cylindrical tablet |
|---|
| Note | ONLINE |
|---|
| License Owner | MUNGMISAI PHARMACEUTICAL SOLE CO.,LTD |
|---|
| Manufacturer | SHENZHEN SCIENCARE PHARMACEUTICAL CO., LTD |
|---|
| Country | CHINA |
|---|
| Import Registration No | H20240031 |
|---|
| Import Registration Date | 25-06-2024 |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | 2024-10-29 |
|---|
| FDD Registration No | 01 I 5859/25 |
|---|
| FDD Registration Date | 2025-03-07 |
|---|
| Expiry Date | 2030-03-06 |
|---|
